Inflammasome Therapeutics has officially dosed the first patient in a pioneering clinical trial aime...

In a significant leadership shift, Topcon Healthcare announced Ali Tafreshi as its new President and...

Naegis Pharmaceuticals Inc., a life sciences company specializing in inflammation and ophthalmology,...

L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the Unive...

RevOpsis Therapeutics has announced the successful closure of its first seed funding round, securing...

Verana Health has introduced its Qdata Thyroid Eye Disease (TED) module, a new addition to its suite...

LEP Biomedical announced pre-seed funding of €100,000 ($107,000) over two 6-month periods, which the...

SalioGen Therapeutics announced the selection of SGT-1001 as a development candidate for Stargardt d...

Phoenix-Micron announced a new collaboration with ArtiKode Intelligence, a pioneering artificial int...

Ocugen has officially completed dosing in the second cohort of its phase 1/2 ArMaDa trial of OCU410,...